According to TipRanks, Wuensch is a 3-star analyst with an average return of 1.1% and a 51.68% success rate. Wuensch covers the Healthcare sector, focusing on stocks such as Abbott Laboratories, Integra Lifesciences, and Edwards Lifesciences.
MiniMed Group, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $21.40, a 26.40% upside from current levels. In a report released on July 15, Bank of America Securities also maintained a Buy rating on the stock with a $20.00 price target.
Based on MiniMed Group, Inc.’s latest earnings release for the quarter ending April 24, the company reported a quarterly revenue of $837 million and a GAAP net loss of $183 million. In comparison, last year the company earned a revenue of $724 million and had a GAAP net loss of $209 million
